Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection

American Journal of Gastroenterology

Volumn 94, Issue 5, 1999, Pages 1218-1223

  McCarthy, Conor J ^a,b   Crofford, Leslie J ^b   Greenson, Joel ^a   Scheiman, James M ^a  

^a Department of Internal Medicine   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ANTIBIOTIC THERAPY; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC GASTRITIS; CLINICAL ARTICLE; ENZYME LOCALIZATION; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH PARIETAL CELL;

ACUTE DISEASE; CHRONIC DISEASE; CYCLOOXYGENASE 2; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYLORIC ANTRUM;

EID: 0033134894     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01070.x     Document Type: Article

References (15)

1. Scheiman JM. NSAIDs, cytoprotection, and gastrointestinal injury. Gastroenterol Clin N Am 1996;25:279-98.
2. Crofford LJ. COX-1 and COX-2 tissue expression: Implications and predictions. J Rheumatol 1997:(suppl 49)24:15-9.
3. Kargman S, Charleson S, Cartwright M, et al. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts. Gastroenterology 1996;111: 445-54.
4. Mizuno H, Sakamoto C, Matsuda K, et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997;! 12:387-97.
5. Infection with Helicobacter pylori. In: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Schistosomes, Liver Flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61. Lyon, France: International Agency for Research on Cancer, 1994:177-240.
6. Ristimaki A, Honkanen N, Jankala H, et al. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997:57:1276-80.
7. Elta GH, Scheiman JM, Barnett JL, et al. Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. Am J Gastroenterol 1995;90:1089-93.
8. To KF, Chan FKL, Leung WK, et al. Expression of cyclooxygenase 1 (COX-1) and 2) (COX-2) in H. pylori associated gastritis. Gastroenterology 1998;114:A310.
9. Jackson LM, Wu K, Mahida YR, et al. COX-1 expression in human gastric mucosa infected with Helicobacter pylori: Constitutive or induced? Gastroenterol 1998;! 14:A160.
10. Wu KC, Jackson L, Mahida YR, et al. Cyclooxygenase (COXl)-and 2 in human gastric mucosa: Constitutive expression by parietal cells and induction of COX-2 in lamina propria cells proximal to ulcers. Gastroenterol 1998;! 14:A334.
11. Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997;99:2254-9.
12. Thun MJ. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev 1994; 13:279-83.
13. Chan FKL, Sung JJK, Chung SCC, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal antiinflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350:975-9.
14. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998:338:727-34.
15. Romano M, Ricci V, Memoli A, et al. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 1998;273:28560-3.